Branch Retinal Vein Occlusion: What It Is, How It Affects Vision, and How It Is Treated
Understanding Branch Retinal Vein Occlusion
The retina is the light-sensitive layer of tissue at the back of the eye that converts what you see into signals sent to the brain. A network of small veins carries blood away from the retina after it delivers oxygen and nutrients to the nerve cells. In BRVO, one branch of these veins becomes blocked, disrupting normal blood flow and setting off a chain of events that can harm your vision.
When a branch retinal vein becomes blocked, blood and fluid back up and spill into the surrounding retinal tissue. If this fluid reaches the macula (the central portion of the retina responsible for sharp, detailed vision), it causes a type of swelling called macular edema. Macular edema is the most common reason people with BRVO experience vision loss.
Most cases of BRVO develop at a spot called an arteriovenous crossing, a place where a retinal artery and a retinal vein share a common outer tissue layer and cross over each other. When the artery wall thickens and stiffens due to atherosclerosis (hardening of the arteries), it can compress the vein beneath it. This compression creates turbulent blood flow, which encourages the formation of a blood clot, called a thrombus, that blocks the vein entirely. The resulting backup of pressure forces fluid into the retina and, over time, can damage or destroy nerve cells in the affected area.
Retinal vein occlusion comes in two main forms. BRVO involves one branch vein and affects a portion of the retina. Central retinal vein occlusion (CRVO) involves the main retinal vein where all branches meet and typically causes more widespread damage. BRVO is four to six times more common than CRVO. Because BRVO affects a smaller area, it may cause less extensive harm, though vision loss can still be significant when the macula is involved.
One serious complication of BRVO is retinal neovascularization. When a portion of the retina receives too little blood, a condition called ischemia, the body may respond by growing fragile, abnormal new blood vessels on the retinal surface. These vessels are prone to bleeding and scar tissue formation, which can lead to further vision loss or even retinal detachment if not treated promptly.
Risk Factors and Who Is Most Affected
BRVO most often affects people aged 50 and older, though it can occur at any age. Understanding the conditions that raise your risk can help you and your care team take proactive steps to protect your eye health.
Uncontrolled high blood pressure is the single most important systemic risk factor for BRVO. Elevated pressure damages and stiffens artery walls throughout the body, including in the eye, making it more likely that an artery will compress a nearby vein at a crossing point. People with a history of stroke or cardiovascular disease face a similarly elevated risk because these conditions share the same underlying process of blood vessel damage.
Diabetes mellitus contributes to BRVO risk by damaging blood vessel walls and promoting abnormal clotting. When diabetes is combined with high blood pressure and high cholesterol (a cluster of conditions known as metabolic syndrome), the risk for retinal vein occlusion increases substantially. People who have experienced organ damage related to both diabetes and hypertension face a particularly elevated risk.
Several additional conditions can raise the likelihood of developing BRVO.
- Being overweight or obese
- High cholesterol or high triglycerides, also called hyperlipidemia
- Blood disorders that increase clotting tendency, known as thrombophilia
- Conditions that cause blood to become thicker than normal, called blood hyperviscosity
- A personal history of vascular stroke
Advancing age plays a role as well, because blood vessels throughout the body naturally become less flexible over time, making them more vulnerable to compression and blockage.
Recognizing the Symptoms
BRVO often announces itself through sudden, painless changes in vision. Knowing what to watch for can help you seek care before the condition causes lasting harm.
The most recognizable symptom of BRVO is a sudden, painless change in part of your visual field. Many people notice blurred or distorted vision that may appear all at once or worsen over several hours or days. Depending on where the blockage occurs, the area of blurring may be small and off to one side, or it may affect much of the vision in the eye.
Some people with BRVO notice floaters (dark spots, lines, or squiggly shapes that drift across vision). Floaters related to BRVO are caused by small amounts of blood leaking from damaged retinal vessels into the vitreous, the clear gel that fills the inside of the eye. If the blocked vein is located away from the macula, BRVO can sometimes go unnoticed because central vision is not immediately affected.
Any sudden, unexplained change in vision deserves prompt medical attention. Seek care right away if you experience a rapid increase in floaters, flashes of light, a shadow or curtain across part of your vision, or sudden vision loss in one eye. Early evaluation by a retina specialist gives you the best chance of preserving as much vision as possible.
Diagnosis and Testing
Confirming a diagnosis of BRVO involves a combination of a careful eye examination and specialized imaging. Our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, use advanced diagnostic tools to assess the extent of the blockage and guide your treatment plan.
The evaluation begins with a comprehensive dilated eye exam. Special drops are used to widen the pupil so the specialist can examine the retina in detail. During this exam, the retina specialist can identify signs of vein blockage such as swollen blood vessels, areas of bleeding, and fluid within the retinal layers.
Optical coherence tomography (OCT) is a non-invasive imaging test that produces detailed cross-sectional images of the retina. OCT allows the specialist to measure the thickness of the macula and detect even small amounts of swelling. This test is used at the time of diagnosis and at follow-up visits to track how your retina is responding to treatment.
Fluorescein angiography involves injecting a harmless dye into a vein in the arm. As the dye travels through the retinal blood vessels, a specialized camera captures rapid photographs. This test shows precisely where blood flow is blocked, where fluid is leaking, and whether any areas of the retina are ischemic. It also helps the specialist identify whether abnormal new blood vessels have begun to grow.
Treatment Options for BRVO
Treatment for BRVO is focused on reducing macular swelling, improving vision, and preventing complications. The appropriate approach depends on the severity of the blockage, the degree of swelling, and how the eye responds over time.
The primary treatment for macular edema caused by BRVO is a series of intravitreal injections (injections given directly into the eye) of anti-VEGF medication. VEGF stands for vascular endothelial growth factor, a protein that promotes abnormal blood vessel growth and fluid leakage. By blocking VEGF, these medications help reduce swelling in the macula and can meaningfully improve vision. Several anti-VEGF medications are used for BRVO, including aflibercept (Eylea), bevacizumab (Avastin), ranibizumab (Lucentis), and faricimab (Vabysmo), a newer bispecific antibody that may allow for longer intervals between injections. Your retina specialist will recommend the medication best suited to your situation.
Because macular swelling tends to return as the medication wears off, anti-VEGF injections are typically given on a regular schedule. The retina specialist monitors your response using OCT scans and adjusts the treatment interval based on how your eye is doing. Some patients require monthly injections initially, while others may gradually extend the time between treatments. Research has shown that patients who receive consistent anti-VEGF treatment during the first year can achieve meaningful vision gains that are often maintained with ongoing care.
For patients who do not respond adequately to anti-VEGF therapy, corticosteroid options may be considered. The dexamethasone implant (Ozurdex) is a small device placed inside the eye that slowly releases steroid medication over several months. Steroid implants can improve vision in a meaningful portion of people with BRVO. However, they carry risks including elevated eye pressure and accelerated cataract formation, so the retina specialist will carefully weigh the benefits and risks before recommending this approach.
Focal laser treatment is sometimes used for specific cases of BRVO. The procedure uses a laser to create tiny, precise burns around the macula to help seal leaking blood vessels and reduce fluid buildup. While anti-VEGF injections are now the preferred first-line treatment for macular edema, laser therapy remains a useful option in selected situations. When BRVO leads to ischemia and the growth of abnormal new blood vessels, a different type of laser procedure called scatter laser photocoagulation may be recommended to reduce the risk of serious complications such as bleeding inside the eye. Research has shown that scatter photocoagulation significantly reduces neovascularization-related complications.
What to Expect During and After Treatment
Understanding what happens during treatment and in the weeks following can help ease anxiety and prepare you for the journey ahead. Most patients find that the treatment process is manageable and that their care team is there to guide them at every step.
Intravitreal injections are performed in the office. The eye is numbed with anesthetic drops and cleaned with an antiseptic solution before a very fine needle is used to deliver the medication into the vitreous cavity. The entire procedure takes only a few minutes. Most people feel a sensation of pressure or mild discomfort, but the numbing drops minimize pain during the injection.
After an injection, it is common to notice temporary blurred vision, mild redness, or a gritty feeling in the eye. These effects usually resolve within a day or two. Your retina specialist will schedule follow-up visits, typically every four to eight weeks at first, to examine the retina with OCT and determine whether additional treatment is needed. As your condition stabilizes, the time between visits and injections may be extended.
The degree of vision recovery after BRVO varies from person to person. Some individuals regain a significant portion of the vision they lost, while others may have lasting changes depending on how long the blockage went untreated and how much retinal tissue was affected. Early diagnosis and consistent treatment provide the best chance of preserving and improving vision. Patients who begin anti-VEGF treatment promptly and maintain regular follow-up care tend to achieve the best outcomes.
Living Well With Branch Retinal Vein Occlusion
Managing BRVO is not only about the treatments you receive in the office. Protecting your vision over the long term also involves managing your overall health and staying attentive to any changes between appointments.
Because BRVO is closely tied to conditions like high blood pressure, diabetes, and high cholesterol, working with your primary care provider to keep these under control is an essential part of your eye care. Maintaining healthy blood pressure, keeping blood sugar in a good range, and addressing elevated cholesterol all help protect the blood vessels in your retina from further damage.
Between appointments, it helps to pay close attention to your vision every day. An Amsler grid, a simple printed chart with a grid pattern, can help you notice new distortion, blank spots, or worsening of existing changes. Your retina specialist can provide one and explain how to use it. If you notice any sudden changes, contact our office promptly rather than waiting for your next scheduled visit.
Living with changes in vision can feel stressful and overwhelming, and those feelings are completely understandable. Support from family, friends, or a counselor can make a real difference. If vision remains limited despite treatment, low-vision aids such as magnifying devices, large-print materials, and improved lighting can make daily tasks like reading and cooking more manageable. Ask your care team for a referral to a low-vision specialist if these challenges apply to you.
Frequently Asked Questions
These answers address common questions our patients have about BRVO that go beyond the basics covered above.
Yes, having BRVO in one eye does raise the risk of developing another retinal vein occlusion in the same eye or the other eye in the future. The underlying conditions that contributed to the first blockage, such as high blood pressure and atherosclerosis, affect blood vessels in both eyes. Consistently managing your systemic health is the most effective way to reduce this risk, and regular follow-up eye exams help detect any new problems early.
Your retina specialist will use OCT scans at each visit to measure the thickness of the macula and assess how much fluid remains. A reduction in macular thickness is a key sign that the treatment is reducing swelling. You may also notice gradual improvement in the clarity of your vision. It is important to continue attending all scheduled appointments even if your vision feels stable, because the retina can change without obvious symptoms.
Intravitreal injections are considered very safe, and serious complications are uncommon. The most serious potential risk is infection inside the eye, called endophthalmitis, which occurs rarely. Minor side effects such as temporary redness, mild discomfort, or seeing floaters from the injection itself are more common and typically resolve quickly. Your specialist takes careful precautions to minimize all risks, and you will be given specific instructions on what to watch for after each injection.
While no lifestyle change can guarantee prevention, certain habits genuinely support healthier retinal blood vessels. Controlling blood pressure through medication and a low-sodium diet, managing blood sugar if you have diabetes, reducing cholesterol levels, maintaining a healthy weight, staying physically active, and avoiding smoking all contribute to better vascular health in the eye. These steps work alongside your medical treatment, not as a replacement for it.
Some patients are able to reduce or stop injections after a period of stable, dry macular scans, while others require ongoing treatment for longer. The decision depends entirely on how your individual eye responds and whether the swelling returns when treatment intervals are extended. Your retina specialist will work closely with you to find the least frequent treatment schedule that keeps your macula healthy and your vision as stable as possible.
See Our Retina Specialists at Rhode Island Eye Institute
If you have been diagnosed with branch retinal vein occlusion, or if you are experiencing sudden changes in your vision, we encourage you to schedule an evaluation at Rhode Island Eye Institute. Our fellowship-trained retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, bring deep expertise and the latest diagnostic technology to every patient visit. With multiple convenient locations across Rhode Island, our team is here to provide the attentive, specialized care your vision deserves.